Skip to main content

CuePath Innovation

CuePath provides smart stickers for blister packs that automatically record the date and time each pill is removed, replacing unreliable self-reporting with objective adherence data in clinical trials. The printed electronic stickers integrate with common Clinical Trials Management Software including RedCap, and are currently deployed in a major methamphetamine use disorder drug treatment trial across Canada. No identifying patient information passes through CuePath servers, ensuring study data security and integrity.

Traction –/10
Vancouver, Canada · HQ
  • Healthcare Technology
  • Internet of Things
  • Hardware
Updated 7 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Clinical researchers conducting large, distributed drug trials often rely on participant self-reporting for medication adherence, which is unreliable and can compromise trial outcomes. This is especially challenging when studying controlled substances or high-value pills with vulnerable, marginalized, and highly mobile populations, where in-person monitoring is impractical and accurate adherence tracking is critical for regulatory compliance.

Solution

CuePath offers smart stickers for blister packs that automatically record the date and time each pill is removed, replacing self-reporting with objective adherence data. The printed electronic stickers integrate with common Clinical Trials Management Software including RedCap, providing real-time insights into participant behavior. No identifying patient information passes through CuePath servers, ensuring study data security and integrity. Designed initially for addiction and pain management studies, the solution enables researchers to manage trial complexities effectively and handle trials with hundreds of distributed participants without compromising data accuracy.

Target Audience

Primary customers are clinical researchers and trial sponsors conducting large, distributed, placebo-controlled drug trials, particularly those involving controlled substances or high-value pills in addiction and pain management studies.

Features

  • Automatically records the date and time each blister is opened, delivering precise data on medication usage
  • Scalable for large trials with hundreds of distributed participants without compromising data accuracy
  • Seamless integration with common Clinical Trials Management Software, including RedCap, as well as proprietary systems
  • No identifying patient information passes through CuePath servers to ensure study data security and integrity
  • Data provided in formats compatible with analysis tools, tailored to meet specific trial needs
  • Designed for controlled substance and high-value pill-based drug trials, particularly addiction and pain management studies
This profile is AI-generated and may contain inaccuracies.